Cole B J, Cador M, Stinus L, Rivier J, Vale W, Koob G F, Le Moal M
Department of Neuropharmacology, Research Institute of Scripps Clinic, La Jolla, CA 92037.
Brain Res. 1990 Apr 2;512(2):343-6. doi: 10.1016/0006-8993(90)90646-S.
This experiment examined the effects of intracerebroventricular (i.c.v.) administration of a corticotropin-releasing factor (CRF) antagonist on the development of stress-induced sensitization of the behavioral response to amphetamine. Restraint stress was found to enhance both the locomotor response to a s.c. injection of saline and the intensity of stereotypy induced by a s.c. injection of 3.0 mg/kg D-amphetamine. Both of these effects of restraint stress were severely attenuated in rats that had been injected with the CRF antagonist prior to restraint stress. This result is compatible with the hypothesis that CRF is critically involved in initiating behavioral and physiological responses to aversive stimuli.
本实验研究了脑室内注射促肾上腺皮质激素释放因子(CRF)拮抗剂对应激诱导的苯丙胺行为反应敏化发展的影响。发现束缚应激可增强皮下注射生理盐水后的运动反应以及皮下注射3.0mg/kg D-苯丙胺所诱导的刻板行为强度。在束缚应激前注射CRF拮抗剂的大鼠中,束缚应激的这两种效应均被显著减弱。该结果与CRF在启动对厌恶刺激的行为和生理反应中起关键作用的假说相符。